Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By S. Karger AG

9783805567862, 9783318034370

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Subject Index

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425861 ◽

1999 ◽

pp. 454-462

Structure-Activity Studies in the Class of Endocrine-Active Platinum Complexes and Their Consequence for the Design of New Drugs

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425855 ◽

1999 ◽

pp. 427-433

Author(s):

R. Gust ◽

R. Keilitz ◽

K. Schmidt

Keyword(s):

Platinum Complexes ◽

New Drugs ◽

Structure Activity

Development of Antitumor Protein and Polymer Conjugates Using in vitro and in vivo Human Tumor Xenograft Models

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425851 ◽

1999 ◽

pp. 389-395

Author(s):

F. Kratz ◽

T. Roth ◽

I. Fichtner ◽

H. H. Fiebig ◽

C. Unger

Keyword(s):

Human Tumor ◽

Tumor Xenograft ◽

Human Tumor Xenograft ◽

Polymer Conjugates ◽

Xenograft Models

Development of Human Tumor Models for Evaluation of Compounds Which Target Tumor Vasculature

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425833 ◽

1999 ◽

pp. 181-190 ◽

Cited By ~ 1

Author(s):

J. B. Schüler ◽

H. -H. Fiebig ◽

A. M. Burger

Keyword(s):

Human Tumor ◽

Tumor Vasculature ◽

Tumor Models

In vitro Models of Solid-Tumour Biology and Drug Delivery: Implications for and Applications to Target-Orientated Screening for Novel Anticancer Drugs

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425823 ◽

1999 ◽

pp. 67-80 ◽

Cited By ~ 1

Author(s):

R. M. Phillips

Keyword(s):

Drug Delivery ◽

Anticancer Drugs ◽

Solid Tumour ◽

In Vitro Models ◽

Tumour Biology

Clinical Investigation of the Monoclonal Anti-CD20 Antibody Rituximab (IDEC-C2B8) in Patients with B Cell Lymphoma

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425847 ◽

1999 ◽

pp. 343-360

Author(s):

U. Winkler ◽

V. Diehl ◽

A. Engert

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

Clinical Investigation ◽

B Cell Lymphoma ◽

Cd20 Antibody ◽

Anti Cd20

Human Tumor Xenografts: Predictivity, Characterization and Discovery of New Anticancer Agents

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425821 ◽

1999 ◽

pp. 29-50 ◽

Cited By ~ 24

Author(s):

H. H. Fiebig ◽

W. A. Dengler ◽

T. Roth

Keyword(s):

Anticancer Agents ◽

Human Tumor ◽

Human Tumor Xenografts ◽

Tumor Xenografts

2-(4-Aminophenyl)benzothiazoles: Agents with Selective and Potent Antitumour Activity in vitro and in vivo

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425852 ◽

1999 ◽

pp. 397-408 ◽

Cited By ~ 1

Author(s):

M. -S. Chua ◽

T. D. Bradshaw ◽

M. F. G. Stevens

Keyword(s):

Antitumour Activity

The Subrenal Capsule Assay: Biological Properties and Testing Capability

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425825 ◽

1999 ◽

pp. 89-99

Author(s):

A. E. Bogden

Keyword(s):

Biological Properties ◽

Subrenal Capsule Assay ◽

Subrenal Capsule

Title Page / Contents / Preface

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development ◽

10.1159/000425819 ◽

1999 ◽

pp. I-VIII

Keyword(s):

Title Page

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug DevelopmentLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By S. Karger AG

Subject Index

Structure-Activity Studies in the Class of Endocrine-Active Platinum Complexes and Their Consequence for the Design of New Drugs

Development of Antitumor Protein and Polymer Conjugates Using in vitro and in vivo Human Tumor Xenograft Models

Development of Human Tumor Models for Evaluation of Compounds Which Target Tumor Vasculature

In vitro Models of Solid-Tumour Biology and Drug Delivery: Implications for and Applications to Target-Orientated Screening for Novel Anticancer Drugs

Clinical Investigation of the Monoclonal Anti-CD20 Antibody Rituximab (IDEC-C2B8) in Patients with B Cell Lymphoma

Human Tumor Xenografts: Predictivity, Characterization and Discovery of New Anticancer Agents

2-(4-Aminophenyl)benzothiazoles: Agents with Selective and Potent Antitumour Activity in vitro and in vivo

The Subrenal Capsule Assay: Biological Properties and Testing Capability

Title Page / Contents / Preface

Contributions to Oncology - Relevance of Tumor Models for Anticancer Drug Development
Latest Publications